Apr 09, 2026
205:204
For every 204 shares held, investors received 205. The price per share adjusted from $27.00 to $26.87.
The split itself did not change the total investment value.
Advagene Biopharma Co., Ltd. (TPEX:6709) operates in the Biotechnology industry.
Advagene Biopharma Co., Ltd. company overviewAdvagene Biopharma Co., Ltd.'s most recent stock split was on April 9, 2026. It was a 205-for-204 forward split, so shareholders received 205 shares for every 204 they held.
Advagene Biopharma Co., Ltd. (TPEX:6709) has split its stock 3 times: a 122-for-121 split on September 2, 2020, a 223-for-221 split on August 2, 2023, and a 205-for-204 split on April 9, 2026.
Advagene Biopharma Co., Ltd. has split its stock 3 times. This history records 3 forward splits between September 2, 2020 and April 9, 2026.
A stock split divides each share into more shares and lowers the price per share by the same factor, so the total value of a holding does not change. In Advagene Biopharma Co., Ltd.'s 205-for-204 split on April 9, 2026, every 204 shares became 205 shares.
Advagene Biopharma Co., Ltd. has not announced a new split in our records. Its most recent split was on April 9, 2026, less than a year ago. Companies announce splits in advance, and any new TPEX:6709 split will appear on this page.
Already premium?